Preclinical development of ADCT-211, a novel pyrrolobenzodiazepine dimer-based antibody-drug conjugate targeting solid tumors expressing IL13RA2

被引：0
|
作者：
Zammarchi, Francesca
Havenith, Karin
Leatherdale, Ben
Roberts, Britanny
Montolio, Lara
Patel, Afroze
Janghra, Narinder
Alves, Pedro
Zaitseva, Kristina
Kirby, Cecile Oblette Ian
de Haan, Lolke
van Berkel, Patrick H.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1604
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1604
引用
收藏
页数：3
相关论文
共 43 条
  • [1] Preclinical Development of ADCT-601, a Novel Pyrrolobenzodiazepine Dimer-based Antibody-drug Conjugate Targeting AXL-expressing Cancers
    Zammarchi, Francesca
    Havenith, Karin E. G.
    Chivers, Simon
    Hogg, Paul
    Bertelli, Francois
    Tyrer, Peter
    Janghra, Narinder
    Reinert, Halla W.
    Hartley, John A.
    van Berkel, Patrick H.
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (04) : 582 - 593
  • [2] Preclinical activity of ADCT-601, a novel pyrrolobenzodiazepine (PBD) dimer-based antibody-drug conjugate (ADC) targeting AXL-expressing tumors
    Zammarchi, Francesca
    Havenith, Karin
    Chivers, Simon
    Hogg, Paul W.
    Britten, Charlie
    Dissanayake, Sandamali
    Tyrer, Peter
    Bertelli, Francois
    Hutchinson, Ian
    Masterson, Luke
    Howard, Phil
    Hartley, John A.
    van Berkel, Patrick H.
    CANCER RESEARCH, 2018, 78 (13)
  • [3] ADCT-701, a novel pyrrolobenzodiazepine (PBD) dimer-based antibody-drug conjugate (ADC) targeting DLK1-expressing tumors
    Zammarchi, Francesca
    Havenith, Karin
    Chivers, Simon
    Hogg, Paul W.
    Britten, Charlie
    Dissanayake, Sandamali
    Tyrer, Peter
    Bertelli, Francois
    Hutchinson, Ian
    Masterson, Luke
    Howard, Phil
    Hartley, John A.
    van Berkel, Patrick H.
    CANCER RESEARCH, 2018, 78 (13)
  • [4] ADCT-502, a novel pyrrolobenzodiazepine (PBD)-based antibody-drug conjugate (ADC) targeting low HER2-expressing solid cancers
    Zammarchi, F.
    Chivers, S.
    Williams, D. G.
    Adams, L.
    Mellinas-Gomez, M.
    Tyrer, P.
    Corbett, S.
    D'Hooge, F.
    Dissanayake, S.
    Sims, S.
    Havenith, K.
    Howard, P. W.
    Hartley, J. A.
    Van Berkel, P. H.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S28 - S28
  • [5] Mechanistic and benchmarking studies of ADCT-502, a pyrrolobenzodiazepine (PBD) dimer-containing antibody-drug conjugate (ADC) targeting HER2-expressing solid tumors
    Zammarchi, Francesca
    Reinert, Halla W.
    Janghra, Narinder
    Corbett, Simon
    Mellinas-Gomez, Maria
    Chowdhury, Sajidah
    Arora, Neha
    Tyrer, Peter
    Bertelli, Francois
    Williams, David G.
    Howard, Philip W.
    Hartley, John A.
    van Berkel, Patrick H.
    CANCER RESEARCH, 2017, 77
  • [6] Preclinical development of a novel camptothecin-based antibody-drug conjugate targeting solid tumors expressing Claudin-6
    Tsang, Nicola
    Veillard, Nicolas
    Horsley, Elizabeth
    Havenith, Karin
    Janghra, Narinder
    Zaitseva, Kristina
    Oblette, Cecile
    Kirby, Ian
    Hogg, Paul W.
    Zammarchi, Francesca
    de Haan, Lolke
    van Berkel, Patrick H.
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Preclinical development of a novel antibody-drug conjugate targeting "cold" tumors
    Kaplan, Angelo
    Attanasio, Nickolas
    Do, To Uyen T.
    Swaminathan, Sudha
    Bisht, Arnima
    Lou, San Lin
    Allen, Jason
    Boyd, Robert
    Ackroyd, James E.
    Feldman, Gleb
    Rohlff, Christian
    Dusek, Rachel L.
    CANCER RESEARCH, 2018, 78 (13)
  • [8] Preclinical development of ADCT-212, a PSMA-targeted antibody-drug conjugate employing the pyrrolobenzodiazepine dimer SG2000 for PSMA-expressing cancers
    Zammarchi, Francesca
    Havenith, Karin
    de Haan, Lolke
    Kirby, Ian
    Janghra, Narinder
    Gil, Veronica
    Alves, Pedro
    Zaitseva, Kristina
    Kerr, Meghann
    Leatherdale, Ben
    Patel, Afroze
    Thoelke, Marie
    Huang, Shiran
    Hartley, John A.
    van Berkel, Patrick H.
    CANCER RESEARCH, 2023, 83 (07)
  • [9] ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies
    Flynn, Michael J.
    Zammarchi, Francesca
    Tyrer, Peter C.
    Akarca, Ayse U.
    Janghra, Narinder
    Britten, Charles E.
    Havenith, Carin E. G.
    Levy, Jean-Noel
    Tiberghien, Arnaud
    Masterson, Luke A.
    Barry, Conor
    D'Hooge, Francois
    Marafioti, Teresa
    Parren, Paul W. H. I.
    Williams, David G.
    Howard, Philip W.
    van Berkel, Patrick H.
    Hartley, John A.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (11) : 2709 - 2721
  • [10] ADCT-401/MEDI3726, a novel pyrrolobenzodiazepine (PBD)-based antibody-drug conjugate (ADC) targeting PSMA-expressing prostate cancers
    Zammarchi, Francesca
    Chivers, Simon
    Havenith, Karin
    Williams, David G.
    Adams, Lauren
    Mellinas-Gomez, Maria
    Corbett, Simon
    Tyrer, Peter
    D'Hooge, Francois
    Cho, Song
    Dimasi, Nazzareno
    Hinrichs, Mary Jane
    Howard, Phil W.
    Hartley, John A.
    van Berkel, Patrick H.
    CANCER RESEARCH, 2017, 77
12345